Skip to main content
editorial
. 2020 Nov 28;28(1):2–3. doi: 10.3390/curroncol28010002
graphic file with name curroncol-28-00002-i001.gif Dr. Gill is Professor of Medicine at the University of British Columbia and a medical oncologist specializing in gastrointestinal (GI) malignancies at BC Cancer, Vancouver. She received her BSc in Pharmacy and MD from the University of British Columbia in 1996, followed by residencies in Internal Medicine and Medical Oncology. Dr. Gill subsequently completed a fellowship in Gl Oncology at the Mayo Clinic (Rochester, MN) and Master of Public Health at the Harvard School of Public Health. In 2017, she completed her MBA at the Kenan-Flagler School of Business, University of North Carolina. She is actively engaged in education and research, with over 100 peer-reviewed publications and book chapters to her credit. Dr. Gill currently serves as Chair of the Canadian Clinical Trials Group (CCTG) GI Disease Site Committee, and is President-Elect of the Canadian Association of Medical Oncologists.